
Opinion|Videos|April 10, 2025
Operationalizing TAR-200 and Other Delivery Systems in Practice
Experts discuss whether novel delivery systems in non–muscle-invasive bladder cancer (NMIBC) could be easily adopted in clinical practice and the challenges they anticipate in operationalizing TAR-200 and other novel delivery systems in urology practices.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Looking forward, do you believe novel delivery systems in NMIBC could be easily adopted in clinical practices?
- What challenges do you anticipate in operationalizing TAR-200 and other novel delivery systems in urology practices?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA updates in urology: December 2025
2
Daniel Spratt, MD, on using ArteraAI to guide salvage therapy decisions
3
The UroOnc Minute: En bloc resection vs TURBT, with Jeremy Y.C. Teoh, MBBS, FRCSEd, FCSHK, FHKAM
4
Top 10 Urology Times bladder cancer articles of 2025
5



















